{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:53:24Z","timestamp":1768006404592,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jpba.2016.03.056","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T00:31:17Z","timestamp":1459643477000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Simultaneous determination of clofarabine and cytarabine in human plasma by LC\u2013MS\/MS"],"prefix":"10.1016","volume":"125","author":[{"given":"Bo\u017eena","family":"B\u00fcttner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Moritz","family":"Middeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Seeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Knoth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.03.056_bib0005","unstructured":"B.V. Genzyme Europe,European Public Assesment Report Evoltra \u2013 EMEA\/H\/C\/000613 \u2013 S\/0045. (16.03.2015)."},{"key":"10.1016\/j.jpba.2016.03.056_bib0010","first-page":"459","article-title":"Clofarabine (2-chloro-2\u2032-fluoro-2\u2032-deoxyarabinosyladenine)\u2014biochemical aspects of anticancer activity","volume":"68","author":"Majda","year":"2011","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jpba.2016.03.056_bib0015","first-page":"3030","article-title":"Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-(2-deoxy- fluoro-\u03b2-D-arabinofuranosyl) adenine","author":"Xie","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2016.03.056_bib0020","first-page":"2847","article-title":"Metabolism and actions of 2-Chloro-9-(2-deoxy-2-fluoro-\u03b2-D-arabinofuranosyl)-adenine in human lymphoblastoid cells","volume":"55","author":"Xie","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2016.03.056_bib0025","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.89.7.2970","article-title":"Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2 '-arabino-fluoro-2'-deoxyadenosine","volume":"89","author":"Carson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpba.2016.03.056_bib0030","first-page":"1","article-title":"Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial","author":"Middeke","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jpba.2016.03.056_bib0035","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2011.37.9743","article-title":"Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I trial","volume":"30","author":"Faderl","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2016.03.056_bib0040","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.26.4242","article-title":"European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy","volume":"28","author":"Burnett","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2016.03.056_bib0045","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1182\/blood-2007-11-124602","article-title":"Arandomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"112","author":"Faderl","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2016.03.056_bib0050","first-page":"4","article-title":"Simultaneous determination of fludarabine and clofarabine in humanplasma by LC\u2013MS\/MS","volume":"19","author":"Huang","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.03.056_bib0055","article-title":"Determination of the concentration of clofarabine in human plasma by HPLC-mS\/MS","volume":"22","author":"Zhu","year":"2011","journal-title":"China Pharm."},{"key":"10.1016\/j.jpba.2016.03.056_bib0060","article-title":"Determination of clofarabine in human plasma by LC\u2013mS\/MS","volume":"19","author":"Zhang","year":"2010","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.jpba.2016.03.056_bib0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jpba.2007.02.007","article-title":"Comparison of fast liquid chromatography\/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma","author":"Hsieh","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2016.03.056_bib0070","first-page":"1566","article-title":"The plasma and intracellular pharmacokinetics of clofarabine in pediatric leukemia patients","volume":"67","author":"Joel","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2016.03.056_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00280-002-0456-0","article-title":"Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats","author":"Gandhi","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2016.03.056_bib0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/bmc.2876","article-title":"Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection","volume":"27","author":"Uchiyamaa","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2016.03.056_bib0085","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.4155\/bio.11.140","article-title":"HPLC-MS\/MS method for the determination of cytarabine in human plasma","volume":"3","author":"Hilhorst","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2016.03.056_bib0090","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jchromb.2010.05.031","article-title":"Simultaneous determination of cytosine arabinoside: daunorubicin and etoposide in human plasma","volume":"878","author":"Krogh-Madsena","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.03.056_bib0095","unstructured":"Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA), Guideline on bioanalytical method validation. EMEA\/CHMP\/EWP\/192217\/2009 Rev. 1Corr. 2 (2011)."},{"key":"10.1016\/j.jpba.2016.03.056_bib0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00280-010-1376-z","article-title":"Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer","volume":"67","author":"Bonate","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2016.03.056_bib0105","first-page":"6335","article-title":"Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias","author":"Gandhi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2016.03.056_bib0110","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1158\/1078-0432.CCR-05-2664","article-title":"Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment","volume":"12","author":"Gandhi","year":"2006","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516301868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516301868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T19:28:27Z","timestamp":1536866907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516301868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":22,"alternative-id":["S0731708516301868"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.03.056","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of clofarabine and cytarabine in human plasma by LC\u2013MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}